Navigation Links
Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL
Date:10/14/2010

FRAZER, Pa., Oct. 14 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and Drug Administration (FDA).  The GABITRIL REMS consists of a Medication Guide to inform patients about the potential risks associated with the use of GABITRIL.  The implementation of the REMS is a result of FDA's identification in 2008 of an increased risk of suicidal thoughts and behavior with the class of antiepileptic drugs (AEDs) which includes GABITRIL.  The current product labeling already contains a warning that includes this risk.  The addition of a Medication Guide for patients and ongoing assessment of the REMS program is consistent with the company's commitment to safe and appropriate use of its medications.  

The GABITRIL Medication Guide will be available on the product website, www.gabitril.com, and will be dispensed with every prescription.  The three-pronged REMS assessment plan will be implemented on an ongoing basis to evaluate (1) patients' understanding of the potential serious risks associated with the medication; (2) the distribution and dispensing of the Medication Guide; and (3) adherence to distribution and dispensing requirements as well as corrective actions taken to address noncompliance.  In accordance with the approved REMS, the company is currently updating all labeling related to GABITRIL to include the Medication Guide.

Additional information on GABITRIL is available at www.GABITRIL.com or at 1-800-896-5855.  More information on Cephalon and its products is available at www.cephalon.com.  

About GABITRILGABITRIL is ind
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
3. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
4. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
5. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
6. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
7. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
8. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
9. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
10. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
11. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , August 29, 2014 ... participate in the inaugural Tweetchat taking place in ... Worldwide , organised by UBM Live , ... #CPhIChat is a first of its kind global ... across the supply chain, aimed to stimulate conversations ...
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces that ... in its catalogue: Needle-Free Delivery: ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html Report ... and commercial prospects What does the future ... brand new report shows you the potential ...
(Date:8/28/2014)... DALLAS , Aug. 28, 2014 /PRNewswire-iReach/ -- ... Poland (Photo - ... " CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Poland ... identifies key trends in the healthcare market and ... and healthcare infrastructure. Most importantly, the report provides ...
Breaking Medicine Technology:CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5
... AMSTERDAM, May 30 Amsterdam Molecular,Therapeutics (Euronext: AMT), ... therapy,today announced that positive interim data from its ... were presented by the,Principal Investigator, professor Daniel Gaudet, ... in Boston on May 29th. These data confirm ...
... CHELMSFORD, Mass., May 29 Magellan Biosciences, ... feature,automated systems and assays designed to streamline ... at the 108th meeting of the,American Society ... and Dynex Technologies, will share booth 743 ...
Cached Medicine Technology:AMT Announces Positive Interim Clinical Data on its Lead Product AMT-011 2AMT Announces Positive Interim Clinical Data on its Lead Product AMT-011 3Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743 2Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743 3
(Date:8/29/2014)... HealthDay Reporter THURSDAY, Aug. ... American babies are getting the vaccines they need to ... Thursday. More than 90 percent of children are ... (MMR); polio; hepatitis B and chickenpox (varicella), according to ... "Nationally, vaccination among children 19 to 35 months of ...
(Date:8/29/2014)... Floors of hospitals and other medical facilities tend ... patients are relegated to lying down or sitting due ... Two inventors from Perrysburg, Ohio, have designed the patent-pending ... special pair of socks helps prevent slips and falls ... relegated to beds or chairs from standing and walking ...
(Date:8/29/2014)... -- Selling cigarettes in plain packages doesn,t increase the ... sales in small stores, according to new research from ... industry when it tried to prevent Australia from becoming ... packaging for tobacco products in 2012. Similar legislation is ... Researchers surveyed nearly 2,000 adult smokers in Australia ...
(Date:8/29/2014)... Vancouver, BC (PRWEB) August 29, 2014 ... announced that the company will now be selling purse-sized ... in such a way that they can be carried ... are they portable, the purse-sized range at Honey Gifts ... A long battery life and rechargeable batteries are common ...
(Date:8/29/2014)... CA (PRWEB) August 29, 2014 Evolutions ... Santa Barbara in the Santa Barbara News-Press Readers’ Choice ... won the Readers’ Choice poll as Best Medical Spa. ... 2014 reads the following about Evolutions Medical Spa recognition: ... but it is recognized as a top-notch, cutting-edge medical ...
Breaking Medicine News(10 mins):Health News:Most U.S. Babies Get Their Vaccines: CDC 2Health News:Most U.S. Babies Get Their Vaccines: CDC 3Health News:Study Counters Critics of Plainer Cigarette Packaging 2Health News:Honey Gifts Now Provides Purse Sized Adult Toys in Vancouver 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3
... A team of international health experts issues a bold call ... They appeal to fund the salaries of health workers or ... diseases are made available in poor countries but there are ... from the inside of the Global Fund," say Gorik Ooms ...
... scarcity has become a universal problem. With a view ... taken up in the country.// ,In a press ... annual rainfall in India is about 1170 mm. However, ... ,The release further said that there had been ...
... of the central nervous system [CNS] in animal evolution ... evolved// from the same ancestor, but their CNSs are ... their lineages had split during evolution. Researchers from the ... that the vertebrate nervous system is probably much older ...
... violence, noise, poor housing or other chronic risk factors ... tissues than other young people. ,However, when ... these negative physiological changes, reports a new study from ... that the cardiovascular systems of youths who are exposed ...
... no monthly bleeding in women or menstruation may come as welcome ... believe it to be the symbol of fertility and would not ... ,This has created a major uproar in the health world ... new pill called Lybrel. This pill is designed to eliminate periods ...
... effective way to fight leukemia might be to knock out ... new study// shows. ,The findings suggest that a ... own be an effective therapy. ,But such a ... offer an effective one-two punch against drug-resistant forms of chronic ...
Cached Medicine News:Health News:Health Expert’s Appeal to Global Fund to Fight HIV, TB and Malari 2Health News:Stress on Storage and Conservation of Rain Water by Govt of India 2Health News:The Origin of the Brain Lies in a Worm 2Health News:Family Turmoil and Violence Results in Stress-induced Physical Problems in Young, Cornell Psychologist Finds 2Health News:Period Eliminating Pills 2Health News:Knocking Out Survival Protein Could Aid Leukemia Treatment 2
Ergotec Vetriretinal Instrument System. Extra fine angled tips (3 mm). 20 gauge shaft tapering to 23 gauge, 10 mm from tip. Overall length from rear rotation knob to tip....
Ergotec Vetriretinal Instrument System. Reverse action jaws. 0.4 mm cupped tips....
Ergotec Vetriretinal Instrument System. Ultra-fine 0.8 mm tips. Angled 40 degrees. 20 gauge shaft tapers to 23 gauge....
Ultra-fine pick shape tips for grasping and manipulating membranes. Stationary distal jaw with black finish for reduced glare....
Medicine Products: